Marc Cobo
Principal Accounting Officer at BridgeBio Oncology Therapeutics, Inc. (BBOT) since April 2026
Marc Cobo has filed 5 insider reports with the SEC since April 2026, as principal Accounting Officer at BridgeBio Oncology Therapeutics, Inc. (BBOT). In the last 12 months Marc Cobo sold $185 of stock on the open market. On November 13, 2026 Marc Cobo filed a Form 144 notice and plans to sell 78 BBOT shares (~$183). In the latest filing, on November 17, 2026, Marc Cobo sold 78 shares of BridgeBio Oncology Therapeutics, Inc. (BBOT) for $185 at an average of $2.37.
Planned sale (Form 144)
- Marc Cobo plans to sell 78 BBOT shares (~$183), around Nov 13, 2026. Notice filed Nov 13, 2026.
A Form 144 is a notice of a proposed sale, not a trade. The sale itself shows up in a later Form 4.
- Filings
- 5
- Companies
- 1
- Bought on market
- None
- Sold on market
- $185
Companies where Marc Cobo is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Principal Accounting Officersince April 2026 | 13,734 | $185 | $1.81 | Nov 17, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Nov 13, 2026-$185BBOTPrincipal Accounting Officer Marc Cobo sold $185 worth of shares (78 units at $2.37) as part of a pre-agreed trading plan, decreasing direct ownership by 0.56% to 13,734 unitsForm 4Open-market sale10b5-1 plan
- Nov 13, 2026~$183BBOTMarc Cobo plans to sell 78 shares (~$183)Form 144Planned sale10b5-1 plan
- Sep 10, 2026BBOTPrincipal Accounting Officer Cobo Marc was granted 9,038 shares and covered exercise/tax liability with 203 shares, increasing direct ownership by 167% to 14,141 units to satisfy withholding taxForm 4Grant or awardShares withheld for taxes or exercise price
- Jul 1, 2026BBOTPrincipal Accounting Officer Cobo Marc covered exercise/tax liability with 125 shares, decreasing direct ownership by 2% to 5,306 units (withholding tax)Form 4Shares withheld for taxes or exercise price
- Apr 21, 2026BBOTNew insider Cobo Marc claimed ownership of 5,431 sharesForm 3New insider
Compare Marc Cobo with
- Marc Cobo vs Pedro Beltran1 shared
- Marc Cobo vs Idan Elmelech1 shared
- Marc Cobo vs Yong Ben1 shared
- Marc Cobo vs Bihua Chen1 shared
- Marc Cobo vs Praveen P. Tipirneni1 shared
- Marc Cobo vs Frank Mccormick1 shared
Other insiders at the same companies
- Pedro BeltranBBOT
- Idan ElmelechBBOT
- Yong BenBBOT
- Bihua ChenBBOT
- Praveen P. TipirneniBBOT
- Frank MccormickBBOT
- Peter F LebowitzBBOT
- Raymond J. KelleherBBOT
- Jake BauerBBOT
- Neil KumarBBOT
- Uneek MehraBBOT
- Eli M. WallaceBBOT
- BridgeBio Pharma LLCBBOT
- Michelle DoigBBOT
- Nebojsa ObradovicBBOT
- Caleb TrippBBOT
Questions about Marc Cobo
- What is Marc Cobo's role at BridgeBio Oncology Therapeutics, Inc.?
- Marc Cobo reports to the SEC as principal Accounting Officer at BridgeBio Oncology Therapeutics, Inc. (BBOT), according to the latest filing on November 17, 2026.
- How many shares does Marc Cobo own?
- After the latest filing that states it, Marc Cobo directly owned 13,734 shares of BridgeBio Oncology Therapeutics, Inc. (BBOT). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Marc Cobo bought or sold stock recently?
- The most recent open-market sale was on November 13, 2026: sold 78 shares of BridgeBio Oncology Therapeutics, Inc. (BBOT) for $185 at an average of $2.37.
- How do I get alerts when Marc Cobo files?
- Follow Marc Cobo on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Marc Cobo filed 3 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Marc Cobo (SEC CIK 0001816654). Totals count each trade once, skipping amendments whose original is on file, from Apr 30, 2026 on. View on SEC EDGAR · Get this as JSON